Key Metrics
CiteScore 

3
H-Index 

22
SJR 

Q2Pharmacology

SNIP 

0.79
Recommended pre-submission checks
Powered by 

Topics Covered on Pharmaceutical Medicine
Pharmaceutical Medicine Journal Specifications
| Overview | |
| Publisher | SPRINGER INT PUBL AG |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pharmaceutical Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Pharmaceutical Medicine
A Framework for Standardising Toxicity Management Guidelines in Oncology Clinical Trials.
- 22 Jun 2026
- Pharmaceutical medicine
Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007-2024) Reported in the ClinicalTrials.gov Database.
- 22 Jun 2026
- Pharmaceutical medicine
Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.
- 19 Jun 2026
- Pharmaceutical medicine
An Expert Consensus-Based Review of Considerations for Developing a Quality Management System Framework for Studies Utilising Secondary Data for Real-World Evidence Generation.
- 6 Jun 2026
- Pharmaceutical medicine
Optimising Formulations for Paediatric Patients with Inherited Metabolic Disorders: The Case Study of Levocarnitine.
- 4 Jun 2026
- Pharmaceutical medicine
Regulating the Irregular: Phage Therapy and the Case for a Regulatory Sandbox Approach in Australia.
- 4 Jun 2026
- Pharmaceutical medicine
A Framework for Standardising Toxicity Management Guidelines in Oncology Clinical Trials.
- 22 Jun 2026
- Pharmaceutical medicine
Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007-2024) Reported in the ClinicalTrials.gov Database.
- 22 Jun 2026
- Pharmaceutical medicine
Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis.
- 19 Jun 2026
- Pharmaceutical medicine
An Expert Consensus-Based Review of Considerations for Developing a Quality Management System Framework for Studies Utilising Secondary Data for Real-World Evidence Generation.
- 6 Jun 2026
- Pharmaceutical medicine
Optimising Formulations for Paediatric Patients with Inherited Metabolic Disorders: The Case Study of Levocarnitine.
- 4 Jun 2026
- Pharmaceutical medicine
Regulating the Irregular: Phage Therapy and the Case for a Regulatory Sandbox Approach in Australia.
- 4 Jun 2026
- Pharmaceutical medicine